Scientists from the Research SCRIPPS institution of Oceanography (USA) has developed a vaccine that helps to block HIV infection in experimental monkeys for 40 weeks after vaccination.

Scientists from the Research SCRIPPS institution of Oceanography (USA) has developed a vaccine that helps to block HIV infection in experimental monkeys for 40 weeks after vaccination. The study results were published in the journal Nature.

Image: The Verge

the New vaccine stimulates the body in experimental monkeys to produce a special protein, which subsequently blocks the sites of the HIV virus responsible for the fixing of the cells of the infected organism. Thus, the medicine enables you to prevent the spread of rotavirus.

After testing of the drug, it was found that the vaccine successfully deals with the prevention of infection in experimental monkeys SHIV, a variant of HIV that are used for laboratory tests on primates. Scientists said that the drug successfully blocks even 16-fold dose of rotavirus.

the Next phase of the experiment will be the modernization of vaccine to stop the replication of HIV in infected monkeys, and then begin testing the drug in humans.

the Researchers hope that with luck they will be able to proceed to clinical trials of the drug on patients already this year.

See also: Scientists have proposed a new way to fight cancer >>